☆ 4.7 Article

LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring

PHARMACEUTICS (2023)

Related references

Note: Only part of the references are listed.

Review Medical Laboratory Technology

Bioanalytical Methods for Poly(ADP-Ribose) Polymerase Inhibitor Quantification: A Review for Therapeutic Drug Monitoring

Marco Orleni et al.

Summary: This literature review explores the pharmacological features of poly(ADP-ribose) polymerase inhibitors (PARPis) that support therapeutic drug monitoring (TDM) and provides a detailed discussion of liquid chromatography coupled with tandem mass spectrometry methods for quantification. TDM can reduce toxicity and improve efficacy of PARPis therapy, and it could be beneficial for studying exposure-response relationships and establishing pharmacokinetic thresholds for clinical decisions. Method transferability and validation play a key role in method selection.

THERAPEUTIC DRUG MONITORING (2023)

Add to Collection

Review Pharmacology & Pharmacy

Pharmacokinetics and Pharmacodynamics of PARP Inhibitors in Oncology

Maaike A. C. Bruin et al.

Summary: Olaparib, niraparib, rucaparib, and talazoparib are PARP inhibitors used for the treatment of various cancers. They have different dosing regimens, pharmacokinetic properties, and associations with drug-drug interactions and toxicity.

CLINICAL PHARMACOKINETICS (2022)

Add to Collection

Article Biochemical Research Methods

A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer

Ariana Soledad Poetto et al.

Summary: Therapeutic drug monitoring (TDM) is essential for defining proper drug dosage in cancer treatment. A new LCMS/MS method for analyzing DBS samples containing PALBO, RIBO, and LETRO has been developed to improve the accuracy of drug exposure monitoring. This method is fast, easy, and reproducible for clinical use.

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2021)

Add to Collection

Review Oncology

Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis

Francesco Schettini et al.

Summary: The study demonstrated the significant role of PARPis in the treatment of metastatic solid tumors, improving PFS, ORR, and OS regardless of the presence of BRCA1/2 mutations. Subgroup analysis revealed significant differences in outcomes based on tumor site, treatment line, control arm, and type of PARPi used.

EUROPEAN JOURNAL OF CANCER (2021)

Add to Collection

Review Chemistry, Multidisciplinary

Dried Blood Spot Technique Applied in Therapeutic Drug Monitoring of Anticancer Drugs: a Review on Conversion Methods to Correlate Plasma and Dried Blood Spot Concentrations

Valentina Iacuzzi et al.

Summary: This review critically investigates the DBS-to-plasma concentration conversion methods proposed and applied in the last decade for quantitative bioanalysis of anticancer drugs in DBS matrix, highlighting the need to address challenges in comparing drug concentrations obtained from DBS with those obtained from reference matrix to ensure treatment efficacy.

PHARMACEUTICAL RESEARCH (2021)

Add to Collection

Article Chemistry, Analytical

Quantification of ribociclib in dried blood spots by LC-MS/MS : Method development and clinical validation

C. Louwrens Braal et al.

Summary: A reliable and specific LC-MS/MS method was developed for determining ribociclib in both DBS samples and plasma. The method met FDA guidelines for validation and showed a strong correlation between ribociclib concentrations in DBS and plasma. This study demonstrates the potential of using DBS for monitoring ribociclib levels in breast cancer patients.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2021)

Add to Collection

Review Pharmacology & Pharmacy

Therapeutic drug monitoring of oral targeted antineoplastic drugs

Anna Mueller-Schoell et al.

Summary: Oral targeted antineoplastic drug (OAD) therapy is important for cancer patients, but high pharmacokinetic variability and low treatment adherence are risk factors for treatment failure. Therapeutic drug monitoring (TDM) can help individualize drug dosing and ensure treatment success.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2021)

Add to Collection

Article Oncology

Evaluation of absorption, distribution, metabolism, and excretion of [14C]-rucaparib, a poly(ADP-ribose) polymerase inhibitor, in patients with advanced solid tumors

Mingxiang Liao et al.

INVESTIGATIONAL NEW DRUGS (2020)

Add to Collection

Article Biochemical Research Methods

Quantification of cobimetinib, cabozantinib, dabrafenib, niraparib, olaparib, vemurafenib, regorafenib and its metabolite regorafenib M2 in human plasma by UPLC-MS/MS

Stefanie D. Krens et al.

BIOMEDICAL CHROMATOGRAPHY (2020)

Add to Collection

Article Biochemical Research Methods

Development and validation of an integrated LC-MS/MS assay for therapeutic drug monitoring of five PARP-inhibitors

M. A. C. Bruin et al.

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2020)

Add to Collection

Review Biotechnology & Applied Microbiology

Poly(ADP-ribose) polymerase inhibition: past, present and future

Nicola J. Curtin et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

Add to Collection

Article Pharmacology & Pharmacy

Individualized dosing of oral targeted therapies in oncology is crucial in the era of precision medicine

Stefanie L. Groenland et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2019)

Add to Collection

Review Medical Laboratory Technology

Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Development and Validation of Dried Blood Spot-Based Methods for Therapeutic Drug Monitoring

Sara Capiau et al.

THERAPEUTIC DRUG MONITORING (2019)

Add to Collection

Article Biochemical Research Methods

A simple and fast LC-MS/MS method for the routine measurement of cabozantinib, olaparib, palbociclib, pazopanib, sorafenib, sunitinib and its main active metabolite in human plasma

Julia Jolibois et al.

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2019)

Add to Collection

Article Pharmacology & Pharmacy

Efficacy and Safety Exposure-Response Analyses of Olaparib Capsule and Tablet Formulations in Oncology Patients

Diansong Zhou et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)

Add to Collection

Article Medical Laboratory Technology

Development and Validation of a Simultaneous Quantification Method of Ruxolitinib, Vismodegib, Olaparib, and Pazopanib in Human Plasma Using Liquid Chromatography Coupled With Tandem Mass Spectrometry

Claire Pressiat et al.

THERAPEUTIC DRUG MONITORING (2018)

Add to Collection

Article Biochemical Research Methods

Liquid chromatography-tandem mass spectrometry assay for the quantification of niraparib and its metabolite M1 in human plasma and urine

L. van Andel et al.

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2017)

Add to Collection

Article Oncology

Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial

Elizabeth M. Swisher et al.

LANCET ONCOLOGY (2017)

Add to Collection

Review Pharmacology & Pharmacy

Practical Recommendations for Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology

Remy B. Verheijen et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)

Add to Collection

Article Chemistry, Analytical

Ultra-high performance liquid chromatography tandem mass spectrometric method for the determination of tamoxifen, N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in dried blood spots-Development, validation and clinical application during breast cancer adjuvant therapy

Marina Venzon Antunes et al.

TALANTA (2015)

Add to Collection

Article Biochemical Research Methods

What is the right blood hematocrit preparation procedure for standards and quality control samples for dried blood spot analysis?

Remco A. Koster et al.

BIOANALYSIS (2015)

Add to Collection

Article Chemistry, Analytical

Liquid chromatography-tandem mass spectrometric assay for the PARP inhibitor rucaparib in plasma

Rolf W. Sparidans et al.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2014)

Add to Collection

Editorial Material Biochemical Research Methods

Current strategies for coping with the hematocrit problem in dried blood spot analysis

Pieter M. M. De Kesel et al.

BIOANALYSIS (2014)

Add to Collection

Article Biochemical Research Methods

Development and validation of a high-performance liquid chromatography-tandem mass spectrometry assay quantifying olaparib in human plasma

C. M. Nijenhuis et al.

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2013)

Add to Collection

Article Oncology

The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial

Shahneen K. Sandhu et al.

LANCET ONCOLOGY (2013)

Add to Collection

Article Biochemical Research Methods

Liquid chromatography-tandem mass spectrometric assay for the PARP-1 inhibitor olaparib in combination with the nitrogen mustard melphalan in human plasma

Rolf W. Sparidans et al.

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2011)

Add to Collection

Article Chemistry, Medicinal

A Convenient Method to Measure Blood-Plasma Concentration Ratio Using Routine Plasma Collection in In Vivo Pharmacokinetic Studies

Leonid M. Berezhkovskiy et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2011)

Add to Collection

Article Medicine, General & Internal

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.

Peter C. Fong et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Add to Collection

Article Chemistry, Analytical

Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS

BK Matuszewski et al.

ANALYTICAL CHEMISTRY (2003)

Add to Collection

Article Biochemical Research Methods

Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography-tandem mass spectrometry

C Polson et al.

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)

Add to Collection

Article Biochemical Research Methods

Linear regression for calibration lines revisited: weighting schemes for bioanalytical methods

AM Almeida et al.

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.